Distinct AD “subtypes” have been identified recently6,10,11 in histopathological brain tissue analyses12 as well as tau positron emission tomography (PET) and structural magnetic resonance imaging (MRI) studies13–22. This evidence concerns the gene MAPT and Alzheimer disease.